First Trust Advisors
MRNS

First Trust Advisors’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History

First Trust Advisors’s Portfolio MRNS Stock Details MRNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-85,567
Closed -$1.53M – 2664
2021
Q2 		$1.53M Sell
85,567
-572
-0.7% -$9.2K ﹤0.01% 1904
2021
Q1 		$1.33M Buy
86,139
+18,042
+26% +$261K ﹤0.01% 1886
2020
Q4 		$831K Sell
68,097
-2,973
-4% -$41.4K ﹤0.01% 1972
2020
Q3 		$913K Buy
+71,070
New +$613K ﹤0.01% 1804

Other funds holding MRNS

LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

First Trust Advisors's MRNS Position: Q3 2021 in Review

First Trust Advisors sold out of Marinus Pharmaceuticals, Inc (MRNS) in Q3 2021, closing a stake of 85,567 shares — an estimated $1.53M sold.

First Trust Advisors first reported a position in MRNS in Q3 2020 and held it in 4 quarters. The position peaked at $1.53M in Q2 2021. 82 funds tracked by Wall St. Rank hold MRNS as of Q3 2021.

  • First Trust Advisors reported no remaining Marinus Pharmaceuticals, Inc position as of Q3 2021 after selling out during the quarter.
  • First Trust Advisors sold 85,567 Marinus Pharmaceuticals, Inc shares in Q3 2021, an estimated $1.53M.
  • First Trust Advisors first reported a position in Marinus Pharmaceuticals, Inc in Q3 2020 and held it in 4 quarters.
  • First Trust Advisors's Marinus Pharmaceuticals, Inc position peaked at $1.53M in Q2 2021.
  • 82 funds tracked by Wall St. Rank held Marinus Pharmaceuticals, Inc as of Q3 2021.

Based on First Trust Advisors's 13F filing for Q3 2021, filed 15 Nov 2021.